<!DOCTYPE html>
<html lang="en">

<!-- defines the default zoom for mobile devices -->
<meta name="viewport" content="width=device-width, initial-scale=1" />
<head>
  <meta charset="UTF-8">
 <title>CardioRef: AHA/ACC 2015 Sports Participation Selector Guide: Mitral Regurgitation</title>

 <link rel="stylesheet" href="css/sports_answer_combined.css">

<style>
div{
    -webkit-margin-before:0;
    -webkit-margin-after:0;
    -webkit-margin-start:0;
    -webkit-margin-end:0;
}

</style>

</head>

<body>

      <div class="topbar">
        <a href="index.html">Pedi CardioRef</a>
        <div class="guidelinebar">
        <a target="_blank" rel="noopener noreferrer" href="https://www.ahajournals.org/doi/10.1161/CIR.0000000000000241">
          Reference: ACC/AHA Sports Participation Recommendations (Circulation 2015) Task Force 5: Valvular Heart Disease</a>
        </div>
      </div>
      
<section style="margin:10px">
  <p class="topspace"></p>

<label><b>By the ACC/AHA 2015 guidelines, should my patient with</label>
  <select name="disease" id="dz" class="InputBox" onChange="goThere();">
  <option value="">*Select Disease*</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="HCM">Hypertrophic Cardiomyopathy </option>
  <option value="LVNC">Left Ventricular Non-Compaction </option>
  <option value="DilRestr">Dilated or Restrictive Cardiomyopathy </option>
  <option value="ARVC">Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) </option>
  <option value="Myo">Myocarditis </option>
  <option value="Peri">Pericarditis </option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="ASDVSDPDA">ASD, VSD, or PDA </option>
  <option value="PS">Pulmonic Stenosis </option>
  <option value="AS">Aortic Stenosis </option>
  <option value="Coarct">Coarctation </option>
  <option value="Cyan">Cyanotic Heart Disease, unrepaired or with palliative shunt </option>
  <option value="TOF">Tetralogy of Fallot, s/p repair </option>
  <option value="TGA_Must">d-transposition (d-TGA), s/p atrial switch (Mustard/Senning)</option>
  <option value="TGA_Art">d-transposition (d-TGA), s/p arterial switch </option>
  <option value="CCTGA">Congenitally-corrected TGA (CC-TGA, L-TGA)</option>
  <option value="Fontan">Fontan </option>
  <option value="Ebstein">Ebstein Anomaly </option>
  <option value="AnomCoronary">Anomalous Coronary Artery Origin</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="PVR">Pulmonary hypertension in CHD </option>
  <option value="VentricularDysfxn">Ventricular Dysfunction s/p CHD Surgery</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="Valve_AS">Aortic Stenosis</option>
  <option value="Valve_AR">Aortic Regurgitation </option>
  <option value="Valve_MS">Mitral Stenosis</option>
  <option value="Valve_MR">Mitral Regurgitation </option>
  <option value="Valve_Hx">History of Cardiac Valve Surgery</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="HTN">Hypertension </option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="Marfan">Aortic Diseases and Marfan Syndrome</option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="CoronaryOverview">Coronary Artery Disease </option>
  <option value ="" class="dropdown-divider">---------------------------------------------------------------</option>
  <option value="Syncope">Syncope </option>
  <option value="Arrhythmia">Arrhythmias (SVT, PVC, Vtach, etc.) </option>
  <option value="ConductionDefect">Conduction Defects (AV block, brady, pacemaker, RBBB/LBBB)</option>
  <option value="Channelopathies">Channelopathies (LQTS, CPVT, Brugada, etc.) </option>
  <option value="ICD">Implantable Cardioverter-Defibrillator (ICD) </option>
  </select>

<label for="spt">participate in</label>
<select name="sport" id="spt" class="demoInputBox"  onChange="goThere();">
<!-- <option value="">*Select Sport*</option> -->
<option value="_Overview" selected="selected">*Overview*</option>
  </select>?</b>
<br><br>
<section id="question">
Should my patient with <b>Mitral Regurgitation</b> participate in organized sports?
</section>
  </section>
<br>
<section id="needtoknow">
  <p class="sectiontitle">Should perform:</p>
  <ul>
  <li>Annual assessment</li>
  <li>Exercise testing</li>
  </ul>
  <p>"Athletes with MR should be evaluated annually
    to determine whether sports participation can continue (Class I; Level of Evidence C)."</p>
  <p>"Exercise testing to at least the level of activity achieved in competition and the training regimen is
useful in confirming asymptomatic status in patients with MR (Class I; Level of Evidence C)."</p>
</section>

<p class="arrows">&#11019 &nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp &#11019 &nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp &#11018; &nbsp&nbsp&nbsp&nbsp&nbsp&nbsp&nbsp &#11018;</p>

<section id="answer">

<section class="quarter_left">
<p class="sectiontitle">Mild-mod MR, sinus rhythm, normal LV size/function, normal PA pressures</p>
<p>"Athletes with mild to moderate MR who are in sinus rhythm with normal LV size and function
  and with normal pulmonary artery pressures (stage B)
  can participate in all competitive sports (Class I; Level of Evidence C)."
</p>
<div class="verdict_ok">All sports = acceptable</div>
<br>
</section>

<section class="quarter_middleleft">
<p class="sectiontitle">Mod MR, sinus rhythm, normal LV systolic function at rest, mild LV enlargement c/w athletic training</p>
<p>
"It is reasonable for athletes with moderate MR in sinus rhythm with normal LV systolic function at rest
and mild LV enlargement (compatible with that which may result solely from athletic training
[LVEDD < 60 mm or < 35 mm/m2 in men or < 40 mm/m2 in women])
to participate in all competitive sports (stage B) (Class IIa; Level of Evidence C)."
</p>
<div class="verdict_maybe">Non-Class IA = Maybe (see conditions above)</div><br>
</section>

<section class="quarter_middleright">
<p class="sectiontitle">Severe MR, sinus rhythm, normal LV function at rest, mild LV enlargement c/w athletic training</p>
<p>
"Athletes with severe MR in sinus rhythm with normal LV systolic function at rest and mild LV enlargement
(compatible with that which may result solely from athletic training
[LVEDD < 60 mm or < 35.3 mm/m2 in men or < 40 mm/m2 in women]) can participate in low-intensity
and some moderate-intensity sports (classes IA, IIA, and IB) (stage C1) (Class IIb; Level of Evidence C)."
</p>
<div class="verdict_maybe">Class IA, IIA, and IB sports = likely acceptable</div><br>
</section>

<section class="quarter_right">
<p class="sectiontitle">Definite LV enlargement, pulmonary HTN, or LV systolic dysfunction at rest</p>
<p>
"Athletes with MR and definite LV enlargement (LVEDD ≥65 mm or ≥35.3 mm/m2 [men] or ≥40 mm/m2 [women]),
pulmonary hypertension, or any degree of LV systolic dysfunction at rest (LV ejection fraction < 60% or LVESD > 40 mm)
should not participate in any competitive sports,
with the possible exception of low-intensity class IA sports (Class III; Level of Evidence C)."
</p>
<div class="verdict_no">Sports = inadvisable. Possible exception for Class IA sports.</div><br>
</section>

</section>

<hr style="width:50%"><br>

<section id="notrecommend">
  <p class="sectiontitle_notrec">Not Recommended</p>
<p>
  <span class="sectiontitle">Patients on long-term anticoagulation:</span>
  "Athletes with a history of atrial fibrillation who are receiving long-term anticoagulation should
  not engage in sports involving any risk of bodily contact (Class III; Level of Evidence C)."</p>
</section>

<p class="foot">
  <b>Reference:</b> <a href="https://www.ahajournals.org/doi/epub/10.1161/CIR.0000000000000241">
    <i>Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities. Task Force 5: Valvular Heart Disease.
    A Scientific Statement From the AHA and ACC.</i></a> <i>Circulation 2015</i>
  <br><br><b>Disclaimer:</b> This website is derived from published guidelines, but does not constitute medical advice nor does it replace clinical judgement. Only the text in quotation marks are direct quotations from the original guidelines. Text not in quotations as well as the method of information display are all that of the website creator and are not part of the original published guidelines. Please consult a physician to discuss any patient-specific matters.
</p>

<section class="key">
<p><b>Key:</b> MR = mitral regurgitation, mod = moderate, PA = pulmonary artery, LV = left ventricle, c/w = consistent with
</p>
</section>


<script>

function goThere(){
  var disease = document.getElementById("dz").value;
  location.href= disease+'_Overview.html';
}

function getState() {
    var disease = document.getElementById("dz").value;
    var sport = document.getElementById("spt").value;
    if(disease && sport) {
      console.log(disease);
      console.log(sport);
      console.log(disease+sport);
      combo=disease+sport;
location.href = combo+'.html';

    }
}

function toggle_table() {
  var x = document.getElementById("elaboration");
  if (x.style.display === "block") {
    x.style.display = "none";
  } else {
    x.style.display = "block";
  }
}

  </script>

</html>
